FDA advises pregnant women to avoid some migraine meds

05/6/2013 | USA Today · Hill, The

The FDA cautioned against the use of migraine treatment valproate sodium in pregnant women because it may lower the IQ score in their children. The agency cited recent research showing lower IQ scores in 6-year-old children who were exposed to such treatment while in the womb, compared with those who were exposed to other anti-seizure drugs. "Valproate medications should never be used in pregnant women for the prevention of migraine headaches because we have even more data now that show the risks to the children outweigh any treatment benefits for this use," said Russell Katz, director of the FDA's Division of Neurology Products.

View Full Article in:

USA Today · Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Medical Director - Physician
Willamette Valley Community Health
Salem, OR